Table 1. Correlative analysis of CRMP4 expression levels and clinical characteristics of gastric tumors.
| Clinicalcharacteristics | Casenumber | CRMP4 | X2 | P-Value | |
|---|---|---|---|---|---|
| high(n, %) | low(n, %) | ||||
| Gender | 1.124 | 0.289 | |||
| Male | 104 | 60(57.7) | 44(42.3) | ||
| Female | 61 | 30(49.2) | 31(50.8) | ||
| Age | 0.542 | 0.462 | |||
| ≤60 | 104 | 59(56.7) | 45(43.3) | ||
| >60 | 61 | 31(50.8) | 30(49.2) | ||
| Lymph node metastasis | 7.998 | 0.005 | |||
| No | 58 | 23(39.7) | 35(60.3) | ||
| Yes | 107 | 67(62.6) | 40(37.4) | ||
| TNM stage | 10.792 | 0.013 | |||
| I | 31 | 11(35.5) | 20(64.5) | ||
| II | 24 | 10(41.7) | 14(58.3) | ||
| III | 50 | 28(56.0) | 22(44.0) | ||
| IV | 60 | 41(68.3) | 19(31.7) | ||
| Tumor differentiation | 9.000 | 0.003 | |||
| High and medium | 45 | 16(35.6) | 29(64.4) | ||
| Low and none | 120 | 74(61.7) | 46(38.3) | ||
| Tumor size | 0.207 | 0.649 | |||
| ≤4cm | 87 | 46(52.9) | 41(47.1) | ||
| >4cm | 78 | 44(56.4) | 34(43.6) | ||
Correlation between CRMP4 expression and the clinical characteristics of gastric cancer patients using the X2 test.